Why the study?
Pericardiectomy is the treatment of choice for constrictive pericarditis but carries high morbidity and mortality, making anesthetic management challenging due to risks of postoperative acute heart failure, bleeding, and arrhythmias.
Anesthetic management with advanced monitoring and TEE guidance during pericardiectomy for constrictive pericarditis is associated with high rates of early extubation and survival to discharge.
Anesthetic vigilance remains essential for CP pericardiectomy; retrospective data leaves open optimal protocols.
BACKGROUND: Constrictive pericarditis (CP) is an uncommon disease that limits both cardiac relaxation and contraction. Patients often present with right-sided heart failure as the pericardium thickens and impedes cardiac filling. Pericardiectomy is the treatment of choice for improving hemodynamics in CP patients; however, the procedure carries a high morbidity and mortality, and the anesthetic management can be challenging. Acute heart failure, bleeding and arrhythmias are all concerns postoperatively. METHODS: After IRB approval, we performed the retrospective analysis of 66 consecutive patients with CP who underwent pericardiectomy from July 2018 to May 2022. RESULTS: Most patients had significant preoperative comorbidities, including congestive hepatopathy (75.76%), New York Heart Association Type III/IV heart failure (59.09%) and atrial fibrillation (51.52%). Despite this, 75.76% of patients were extubated within the first 24 h and all but 2 of the patients survived to discharge (96.97%). CONCLUSIONS: Anesthetic management, including a thorough understanding of the pathophysiology of CP, the use of advanced monitoring and transesophageal echocardiography (TEE) guidance, all played an important role in patient outcomes.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: